quantisnow
FeedTopReportsPricing
⌘K
Live feed
11:58:48·863d
NEWSRelease
Achieve Life Sciences Inc. logo
Aditxt Inc. logo
C4 Therapeutics Inc. logo
+4

Dow Jumps Over 100 Points; Oracle Posts Mixed Q2 Results

ACHV· Achieve Life Sciences Inc.ADTX· Aditxt Inc.CCCC· C4 Therapeutics Inc.GGE· Green Giant Inc.HCDI· Harbor Custom Development Inc.ICVX· Icosavax Inc.
Health CareFinanceConsumer Discretionary
Original source

Companies

  • ACHV
    Achieve Life Sciences Inc.
    Health Care
  • ADTX
    Aditxt Inc.
    Health Care
  • CCCC
    C4 Therapeutics Inc.
    Health Care
  • GGE
    Green Giant Inc.
    Finance
  • HCDI
    Harbor Custom Development Inc.
    Consumer Discretionary
  • ICVX
    Icosavax Inc.
    Health Care
  • ORCL
    Oracle Corporation
    Technology

Recent analyst ratings

  • Apr 21ACHVUpdateCanaccord Genuity$13.00
  • Apr 10ORCLUpdateCleveland Research-
  • Mar 24ORCLUpdateBofA Securities$200.00
  • Mar 11ORCLUpdateAnalyst$210.00
  • Mar 11ORCLUpdateBMO Capital Markets$200.00
  • Mar 11ORCLUpdateOppenheimer$210.00

Related

  • SEC14h
    SEC Form 424B3 filed by Aditxt Inc.
  • INSIDER15h
    Large owner Hrt Financial Lp bought $24,061 worth of Class A Shares (72,912 units at $0.33) and sold $3,595 worth of Class A Shares (11,982 units at $0.30), increasing direct ownership by 100% to 121,592 units (SEC Form 4)
  • INSIDER15h
    New insider Hrt Financial Lp claimed ownership of 133,574 units of Class A Shares (SEC Form 3)
  • SEC1d
    Amendment: SEC Form SCHEDULE 13G/A filed by C4 Therapeutics Inc.
  • PR1d
    Oracle Expands Powerful AI Capabilities in Oracle AI Database@Google Cloud to Supercharge Enterprise Data Innovation
  • SEC2d
    SEC Form EFFECT filed by Aditxt Inc.
  • INSIDER2d
    SEC Form 4 filed by Goldberg Andrew D.
  • INSIDER2d
    SEC Form 3 filed by new insider Goldberg Andrew D.
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022